InvestorsHub Logo
Followers 116
Posts 11877
Boards Moderated 1
Alias Born 03/08/2004

Re: CAMY post# 31743

Thursday, 12/27/2012 7:20:55 AM

Thursday, December 27, 2012 7:20:55 AM

Post# of 39209
That's why they are reluctant to publish studies on it

Patents are worth what they are proven to be or what people believe they will be proven to be. IMDS has not brought the CTLM to a level where it is diagnostically useful. The more studies that prove that, the LESS it is worth.

Right now the patents might be worth a few million. At best. The CTLM will need to be further developed. It will then need studies to support it. Then it will need to be FDA approved. Lots of money needed to bring it to market, with no clear indication it will be worth anything even then.

IMDS is not the only one working on optical imaging.

Right now IMDS is similar to a homeowner who is upside down on his house. Owing more than the house is worth. You tend not to do things to improve the value of your house at that point.

IMDS owes about $5 million and needs at least that much more to make it saleable. The total market cap right now of IMDS stock is about $1 million.

That's why you see so little activity out of IMDS beyond the occasional vague press release. That's why Florida preachers are claiming to sell 6 figure medical devices in bannana (borscht) republics.



#1). You have money. Other people want it. All of it!

#2). You want easy money. So does everybody else. They'll get it, too....yours! (and all of it!)

#3). You tell yourself you're smart. You won't lose your money. Fact: Other people are smarter,

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.